ATLANTA, September 22, 2021 / PRNewswire / – CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, today announced the appointment of Anthony “Tony” Semedo to its board of administration from October 1, 2021.
“We are delighted to welcome Tony, a leader in the aortic space, to our board of directors,” commented Pat Mackin, Chairman of the Board, President and Chief Executive Officer. “Tony’s demonstrated ability to lead, develop and integrate diverse global medical device divisions, as well as his experience in managing robust R&D, quality and regulatory functions will be instrumental as we move forward on our growth trajectory. ”
Mr. Semedo said: “I am very excited to join CryoLife as the company continues to grow as a dominant force in the aortic space. I look forward to working with the entire team to support the company’s enduring commitment to enabling positive patient outcomes while providing a diverse portfolio to surgeons around the world. ”
Mr. Semedo has over 40 years of experience in the United States and abroad in the medical device industry, most recently serving as Senior Vice President and President of Operations in Japan at Medtronic, where he served led several business units and functions. During his tenure at Medtronic, Mr. Semedo held a number of leadership roles, including senior vice president and president of the aortic, peripheral and venous (APV) division of the company and senior vice president and president of endovascular innovations. Previously, he was Vice President of Cardiovascular Business at Medtronic in Japan and Global Vice President of Vascular Research and Development. Earlier in his career, he spent time at Alaris Medical Systems, Eli Lilly & Co. and Abbott Laboratories. Mr. Semedo received his Bachelor of Science in Engineering from University of Massachusetts.
About CryoLife, Inc.
Headquarters in the suburbs Atlanta, Georgia, CryoLife is a leader in the manufacture, treatment and distribution of medical devices and implantable tissues used in cardiac and vascular surgeries focused on aortic repair. CryoLife markets and sells products in over 100 countries around the world. For more information on CryoLife, visit our website, www.cryolife.com.
D. Ashley Lee
Executive Vice President, Chief Financial Officer
and chief operating officer
Gilmartin SARL Group
Brian Johnston / Lynn Lewis
SOURCE CryoLife, Inc.